Clinical trials: Prostate Cancer Recurrence After Radical Prostatectomy
- Condition Prostate Cancer Recurrence After Radical Prostatectomy
- Funder type Industry (pharma, biotech, devices)
Prostate Cancer
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence
This study is designed to measure the impact of Satraplatin plus radiation therapy to the bed of the prostate in patients who have developed biochemical failure of their prostate cancer.
- Trial name
- NCT00480623
- Testing
- Satraplatin plus radiation therapy
- Where
- 4 sites in United States
- Sponsor
- Agennix
Prostate Cancer
PROvenge Treatment and Early Cancer Treatment
The PROTECT-PROvenge Treatment and Early Cancer Treatment trial was a Phase III trial for patients with hormone sensitive prostate cancer. The study was conducted at over 15 participating centers throughout the US.
- Trial name
- PROTECT (NCT00779402)
- Testing
- Control, Sipuleucel-T
- Where
- 18 sites in United States
- Volunteers
- 176 people
- Sponsor
- Dendreon
Prostate Cancer
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
- Trial name
- NCT06604442
- Testing
- flotufolastat (18F), piflufolastat (18F)
- Where
- 9 sites in United States
- Volunteers
- 62 people
- Sponsor
- Blue Earth Diagnostics